-
Syncope After Percutaneous Coronary InterventionTsushima T, Sahadevan J, Intini A. -
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al.
-
Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac ArrestYannopoulos D, Bartos JA, Raveendran G et al.
-
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and AdolescentsFlynn JT, Kaelber DC, Baker-Smith CM et al.
-
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO TrialLee SW, Lee PH, Park SJ et al.
-
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries EndorsedV. Aboyans, J-B Ricco, M-L E. L. Bartelink et al
-
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further ResearchCostanzo MR, Ronco C, Abraham WT et al.
-
10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study)McClelland RL, Jorgensen NW, Budoff M et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
